ONCOSPAN Trademark Application for Oncology Research Products

ChangeBridge: Trademarks - Pharmaceuticals (Class 005)

Published March 31st, 2025

Detected April 1st, 2026

Summary

USPTO received trademark application TM99112500 for 'ONCOSPAN' filed March 31, 2025, by a single applicant seeking protection for biological preparations, cell line-derived reference standards, and custom manufacturing services for oncology research products. The application covers goods in International Class 5 including nucleic acid reference standards, FFPE samples, and custom manufactured biological products for clinical diagnostics.

View original document View source feed page

What changed

The application covers a broad range of oncology research products including biological preparations for laboratory and biopharmaceutical processing, cell line-derived nucleic acids and FFPE samples for use as reference standards in next-generation sequencing, droplet-digital PCR, real-time PCR, and Sanger sequencing applications. The goods also include custom manufacturing services for medical and commercial applications and reference standards used for detecting chromosomal abnormalities and analyzing biological samples.

This is a routine trademark application filing that does not impose obligations on other parties. Competitors in the oncology research products space may wish to review the application to assess potential conflicts with their existing marks. The application remains subject to examination by USPTO and potential opposition by third parties before registration.

Source document (simplified)

← USPTO Trademark Applications

ONCOSPAN

Intent to Use TM99112500 Kind: intenttouse Mar 31, 2026

Abstract

Biological preparations for laboratory, biopharmaceutical processing, and research purposes, for use as reference standards in science; Chemicals for use in the research of anti-cancer drugs; Biological preparations for quality control of laboratory research; Cell line-derived nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for use as reference standards for research purpose; Samples made of nucleic acids for use in biochemical or biological laboratory analysis for research purposes; Samples made of formalin and nucleic acids for use in a biochemical or biological laboratory analysis for research purposes; Samples made of formalin and cells for use in a biochemical or biological laboratory analysis for research purposes; Cell line-derived products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for scientific and research purposes, namely, for clinical investigations and for use in product testing; Reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for research purposes, namely, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; Custom manufacture of cell line-delivered products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for medical and commercial applications; Custom manufacture of reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids; cell line-derived reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used in clinical medical samples; reference standard substances in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for clinical tests for medical purposes; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for detecting chromosomal abnormalities; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for analysing biological samples